Diagnosis of oral squamous cell carcinoma and its precursor lesions;Diagnostik des oralen plattenepithelkarzinoms und seiner präkursorläsionen

JDDG - Journal of the German Society of Dermatology

Volumn 5, Issue 12, 2007, Pages 1095-1100

  Driemel, Oliver ^a   Kunkel, Martin ^b   Hullmann, Markus ^a   Eggeling, Ferdinand Von ^c   Müller Richter, Urs ^a   Kosmehl, Hartwig ^d   Reichert, Torsten E ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d HELIOS KLINIKUM ERFURT   (Germany)

Author keywords

Brush biopsy; Oral carcinoma; Oral cytology; Photodynamic diagnosis; Toluidine blue

Indexed keywords

TOLONIUM CHLORIDE;

ANALYTIC METHOD; AUTOFLUORESCENCE; CYTOMETRY; DNA DETERMINATION; EARLY DIAGNOSIS; GOLD STANDARD; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; MOUTH CARCINOMA; ORAL BIOPSY; PHOTODYNAMICS; PRECANCER; QUALITY OF LIFE; RELIABILITY; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; STAINING; SURVIVAL RATE;

BIOPSY; CARCINOMA, SQUAMOUS CELL; FLUORESCENCE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; TOLONIUM CHLORIDE;

EID: 36949001105     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2007.06397.x     Document Type: Review

References (45)

1. Howaldt HP, Vorast H, Blecher JC, Reicherts M, Kainz M. Ergebnisse aus dem DÖSAK-Tumorregister. Mund Kiefer Gesichtschir 2000 4 Suppl 1 : 216 225.
2. Moore SR, Johnson NW, Pierce AM, Wilson DF. The epidemiology of mouth cancer: a review of global incidence. Oral Dis 2000 6 : 65 74.
3. Kowalski LP, Carvalho AL. Influence of time delay and clinical upstaging in the prognosis of head and neck cancer. Oral Oncol 2001 37 : 94 98.
4. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002 38 : 99 166.
5. Zavras A, Andreopoulos N, Katsikeris N, Zavras D, Cartsos V, Vamvakidis A. Oral cancer treatment costs in Greece and the effect of advanced disease. BMC Public Health 2002 2 : 1 8.
6. Scheifele C, Reichart PA. Is there a natural limit of the transformation rate of oral leukoplakia? Oral Oncol 2003 39 : 470 475.
7. El Naggar AK, Reichart PA. Proliferative verrucous leukoplakia and precancerous conditions. In : Barnes L, Eveson JW, Reichart PA, Sidransky D : World Health Organization Classification of Tumours. Pathology and Genetics: Head and Neck Tumours. Lyon : IARC Press, 2005 : 180 181.
8. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003 14 : 47 62.
9. Kujan O, Glenny AM, Duxbury J, Thakker N, Sloan P. Evaluation of screening strategies for improving oral cancer mortality: a cochrane systematic review. J Dent Educ 2005 69 : 255 265.
10. Johnson NW. Oral Cancer. FDI World Dental Press, London, 1999, pp 1 44.
11. Niebel HH, Chomet B. In vivo staining test for delineation of oral epithelial neoplastic change: Preliminary report. J Am Dent Assoc 1964 68 : 801 806.
12. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. Ca Cancer J Clin 1995 45 : 328 351.
13. Epstein JB, Scully C, Spinelli J. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 1992 21 : 160 163.
14. Onofre MA, Sposto MR, Navarro CM. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 91 : 535 540.
15. Ephros H, Mashberg A. Toluidine blue - viewpoints. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999 87 : 526 527.
16. Missmann M, Jank S, Laimer K, Gassner R. A reason for the use of toluidine blue staining in the presurgical management of patients with oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 102 : 741 743.
17. Chang CJ, Wilder-Smith P. Topical application of photofrin for photodynamic diagnosis of oral neoplasms. Plast Reconstr Surg 2005 115 : 1877 1886.
18. Leunig A, Rick K, Stepp H, Goetz A, Baumgartner R, Feyh J. Photodynamische Diagnose von Neoplasien der Mundhöhle nach lokaler Gabe von 5-Aminolävulinsäure. Laryngorhinootologie 1996 75 : 459 464.
19. Betz CS, Stepp H, Janda P, Arbogast S, Grevers G, Baumgartner R, Leunig A. A comparative study of normal inspection, autofluorescence and 5-ALAinduced PPIX fluorescence for oral cancer diagnosis. Int J Cancer 2002 97 : 245 252.
20. Schleier P, Zenk W, Dietel W. Fluoreszenz beim Mundhöhlenkarzinom. HNONachrichten 2002 5 : 22 24.
21. Zenk W, Dietel W, Schleier P, Günzel S. Visualisierung von Karzinomen der Mundhöhle durch Stimulierung der Synthese von fluoreszierendem Protoporphyrin IX. Mund Kiefer Gesichtschir 1999 3 : 205 209.
22. Doss M, Philipp-Dormostro W. Regulatory link between lactate dehydrogenase and biosynthesis of porphyrin and heme in microorganisms. Enzyme 1973 16 : 28 41.
23. Schleier P, Zenk W, Dietel W. Mundhöhlenkarzinome. Nicht alle fluoreszierenden Tumoren sind bösartig. MMW Fortschr Med 2002 144 : 26 28.
24. Betz V, Schneckenburger H, Alleroder HP, Sybrecht GW, Meyer JU. Evaluation of changes in the NADH level between carcinogenic and normal tissue samples by use of fluorescence spectroscopy. Pro SPIE 1994 2324 : 284 291.
25. Policard A. Etude sur les aspects offerts par des tumeurs experimentales examinees a la lumiere de Wood. C R Soc Biol 1924 91 : 1423 1424.
26. Baletic N, Petrovic Z, Pendjer I, Malicevic H. Autofluorescent diagnostics in laryngeal pathology. Eur Arch Otorhinolaryngol 2004 261 : 233 237.
27. DaCosta RS, Andersson H, Cirocco M, Marcon NE, Wilson BC. Autofluorescence characterisation of isolated whole crypts and primary cultured human epithelial cells from normal, hyperplastic and adenomatous colonic mucosa. J Clin Pathol 2005 58 : 766 774.
28. Mehrotra R, Gupta A, Singh M, Ibrahim R. Application of cytology and molecular biology in diagnosing premalignant or malignant lesions. Mol Cancer 2006 5 : 1 11.
29. Sciubba JJ. Improving detection of precancerous and cancerous oral lesions. JADA 1999 130 : 1445 1457.
30. Driemel O, Dahse R, Berndt A, Pistner H, Hakim SG, Zardi L, Reichert TE, Kosmehl H. High-molecular Tenascin- C as an indicator of atypical cells in oral brush biopsies. Clin Oral Investig 2007 11 : 93 99.
31. Remmerbach TW, Weidenbach H, Pomjanski N, Knops K, Mathes S, Hemprich A, Böcking A. Cytologic and DNA-cytometric early diagnosis of oral cancer. Anal Cell Pathol 2001 22 : 211 221.
32. Kujan O, Deasai M, Sargent A, Bailey A, Turner A, Sloan P. Potenzial application of oral brush cytology with liquid-based technology: results from a cohort of normal oral mucosa. Oral Oncol 2006 42 : 810 818.
33. Hullmann M, Reichert TE, Dahse R, von Eggeling F, Pistner H, Kosmehl H, Driemel O. Orale Zytologie - Historische Entwicklung, aktueller Stand und Ausblick. Mund Kiefer Gesichtschir 2007 11 : 1 9.
34. Remmerbach TW, Mathes SN, Weidenbach H, Hemprich A, Böcking A. Nichtinvasive Bürstenbiopsie als innovative Methode in der Früherkennung des Mundhöhlenkarzinoms. Mund Kiefer Gesichtschir 2004 8 : 229 236.
35. Driemel O, Dahse R, Hakim SG, Tsioutsias T, Pistner H, Reichert TE, Kosmehl H. Laminin-5 immunocytochemistry: a new tool for identifying dysplastic cells in oral brush biopsies. Cytopathology 2007 in press).
36. Poate TWJ, Buchanan JAG, Hodgson TA, Speight PM, Barrett AW, Moles DR, Scully C, Porter SR. An audit of the efficacy of the oral brush biopsy technique in e specialist oral unit. Oral Oncol 2004 40 : 829 834.
37. Scheifele C, Schmidt-Westhausen AM, Dietrich T, Reichart PA. The sensitivity and specifity of the OralCDx technique. Oral Oncol 2004 40 : 824 828.
38. Slater LJ. Oral brush biopsy: false positives redux. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004 97 : 419.
39. Maraki D, Becker J, Böcking A. Cytologic and DNA-cytometric very early diagnosis of oral cancer. J Oral Pathol Med 2004 33 : 398 404.
40. Portugal LG, Wilson KM, Biddinger PW, Gluckman JL. The role of toluidine blue in assessing margin status after resection of squamous cell carcinomas of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 1996 122 : 517 519.
41. Epstein JB, Oakley C, Millner A, Emerton S, Meij Van Der E, Le N. The utility of tolouidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 83 : 537 547.
42. Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potenzially malignant epithelial lesions. Int J Oral Maxillofac Surg 2005 34 : 521 527.
43. Gandolfo S, Penetenero M, Brocoletti R, Pagano M, Carrozzo M, Scully C. Toluidine blue uptake in potenzially malignant oral lesions in vivo: clinical and histological assessment. Oral Oncol 2006 42 : 89 95.
44. Leunig A, Betz SC, Mehlmann M, Stepp H, Arbogast S, Grevers G, Baumgartner R. Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acidinduced protoporphyrin IX fluorescence. Laryngoscope 2000 110 : 78 83.
45. Sharwani A, Jerjes W, Salih V, MacRobert AJ, El-Maaytah M, Khalil HS, Hopper C. Fluorescence spectroscopy combined with 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in detecting oral premalignancy. J Photochem Photobiol B 2006 83 : 27 33.